MiniMed Group (MMED) CFO details RSU tax share withholding

Rhea-AI Filing Summary

MiniMed Group, Inc. EVP and Chief Financial Officer Chad Spooner reported a tax-withholding disposition of 23,301 shares of Common Stock on July 28, 2026. These shares were withheld by MiniMed Group to satisfy income tax withholding and remittance obligations tied to vesting Restricted Stock Units. After this withholding, Spooner directly holds 362,707 shares of Common Stock, including shares to be issued upon the vesting of one or more RSUs.

Insider Trade Summary

Net Seller: 23,301 shares

Net Sell 1 txn

Insider Spooner Chad

Role EVP, Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1, F2	23,301	$17.67	$412K

Holdings After Transaction: Common Stock — 362,707 shares (Direct)

Footnotes (2)

1. F1. Represents shares of Common Stock that have been withheld by MiniMed Group Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs").
2. F2. Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs.

Key Figures

Shares withheld for taxes: 23,301 shares Price per withheld share: $17.67 per share Shares owned after transaction: 362,707 shares

3 metrics

Shares withheld for taxes 23,301 shares Code F disposition to satisfy income tax withholding on RSU vesting on July 28, 2026

Price per withheld share $17.67 per share Valuation used for Common Stock withheld to cover RSU-related tax obligations

Shares owned after transaction 362,707 shares Direct Common Stock holdings after withholding, including shares to be issued upon RSU vesting

Key Terms

Restricted Stock Units ("RSUs"), income tax withholding and remittance obligations, net settlement

3 terms

Restricted Stock Units ("RSUs") financial

"in connection with the vesting and net settlement of Restricted Stock Units ("RSUs")"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

income tax withholding and remittance obligations financial

"withheld by MiniMed Group Inc. to satisfy income tax withholding and remittance obligations"

net settlement financial

"in connection with the vesting and net settlement of Restricted Stock Units"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/29/2026 - 07:10 PM Accepted by SEC EDGAR 07/29/2026 - 07:10 PM Learn about SEC filing dates

FAQ

What insider transaction did MiniMed Group (MMED) CFO Chad Spooner report?

Chad Spooner reported a tax-withholding disposition of 23,301 shares of MiniMed Group Common Stock. The company withheld these shares to cover income tax obligations arising from the vesting and net settlement of Restricted Stock Units (RSUs).

Was Chad Spooner’s MMED transaction a market sale of Common Stock?

No. The 23,301 MiniMed shares were withheld by the company to satisfy income tax withholding and remittance obligations for vesting RSUs, rather than sold in an open-market transaction, as indicated by transaction code F and the related footnote.

How many MiniMed Group (MMED) shares does Chad Spooner hold after this transaction?

Following the tax-withholding disposition, Chad Spooner directly holds 362,707 shares of MiniMed Group Common Stock. This amount includes shares that will be issued in connection with the vesting of one or more Restricted Stock Units, according to the disclosure.

At what price were the withheld MMED shares valued in Chad Spooner’s transaction?

The 23,301 withheld shares were valued at $17.67 per share. This per‑share amount is the transaction price used to determine the value of the Common Stock withheld to satisfy income tax obligations related to the vesting of RSUs.

What role do Restricted Stock Units (RSUs) play in this MMED insider transaction?

The transaction stems from the vesting and net settlement of RSUs granted to Chad Spooner. When these RSUs vested, MiniMed withheld 23,301 shares to cover associated income tax obligations, and the reported post-transaction holdings include shares tied to remaining unvested or unissued RSUs.

How is the nature of Chad Spooner’s MMED share ownership characterized after this event?

The reported 362,707 shares are held directly by Chad Spooner. A related footnote clarifies that this figure also includes shares of Common Stock that will be issued upon the vesting of one or more RSUs, reflecting both currently issued and RSU-linked shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Spooner Chad

(Last) (First) (Middle)

C/O MINIMED GROUP, INC.

18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CALIFORNIA 91325

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/28/2026		F		23,301(1)	D	$17.67	362,707(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Common Stock that have been withheld by MiniMed Group Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs").

2. Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs.

Remarks:

	/s/ Bryan F. Kelly, attorney-in-fact	07/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)